Dietary polyphenols can modulate the intestinal inflammatory response
Identifieur interne : 001535 ( Istex/Corpus ); précédent : 001534; suivant : 001536Dietary polyphenols can modulate the intestinal inflammatory response
Auteurs : Béatrice Romier ; Yves-Jacques Schneider ; Yvan Larondelle ; Alexandrine DuringSource :
- Nutrition Reviews [ 0029-6643 ] ; 2009-07.
English descriptors
- KwdEn :
Abstract
Inflammatory bowel diseases (IBD) arise from multiple causes, including environmental factors, gut microflora, immunity, and genetic predispositions. In the course of IBD, immune homeostasis and intestinal mucosa barrier integrity are impaired. Among natural preventive treatments that have been identified to date, polyphenols appear as promising candidates. They have been shown to protect against several diseases, including cardiovascular diseases and cancers, and they have anti‐inflammatory properties in non‐intestinal models. This paper will review the literature that has described to date some effects of polyphenols on intestinal inflammation. Studies, conducted using in vivo and in vitro models, provide evidence that pure polyphenolic compounds and natural polyphenolic plant extracts can modulate intestinal inflammation.
Url:
DOI: 10.1111/j.1753-4887.2009.00210.x
Links to Exploration step
ISTEX:A164F73163EDA0A6840767994EE75691F4B14159Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dietary polyphenols can modulate the intestinal inflammatory response</title><author><name sortKey="Romier, Beatrice" sort="Romier, Beatrice" uniqKey="Romier B" first="Béatrice" last="Romier">Béatrice Romier</name><affiliation><mods:affiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</mods:affiliation></affiliation></author><author><name sortKey="Schneider, Yves Acques" sort="Schneider, Yves Acques" uniqKey="Schneider Y" first="Yves-Jacques" last="Schneider">Yves-Jacques Schneider</name><affiliation><mods:affiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</mods:affiliation></affiliation></author><author><name sortKey="Larondelle, Yvan" sort="Larondelle, Yvan" uniqKey="Larondelle Y" first="Yvan" last="Larondelle">Yvan Larondelle</name><affiliation><mods:affiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</mods:affiliation></affiliation></author><author><name sortKey="During, Alexandrine" sort="During, Alexandrine" uniqKey="During A" first="Alexandrine" last="During">Alexandrine During</name><affiliation><mods:affiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: alexandrine.during@uclouvain.be</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A164F73163EDA0A6840767994EE75691F4B14159</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1111/j.1753-4887.2009.00210.x</idno><idno type="url">https://api.istex.fr/document/A164F73163EDA0A6840767994EE75691F4B14159/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001535</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001535</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Dietary polyphenols can modulate the intestinal inflammatory response</title><author><name sortKey="Romier, Beatrice" sort="Romier, Beatrice" uniqKey="Romier B" first="Béatrice" last="Romier">Béatrice Romier</name><affiliation><mods:affiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</mods:affiliation></affiliation></author><author><name sortKey="Schneider, Yves Acques" sort="Schneider, Yves Acques" uniqKey="Schneider Y" first="Yves-Jacques" last="Schneider">Yves-Jacques Schneider</name><affiliation><mods:affiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</mods:affiliation></affiliation></author><author><name sortKey="Larondelle, Yvan" sort="Larondelle, Yvan" uniqKey="Larondelle Y" first="Yvan" last="Larondelle">Yvan Larondelle</name><affiliation><mods:affiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</mods:affiliation></affiliation></author><author><name sortKey="During, Alexandrine" sort="During, Alexandrine" uniqKey="During A" first="Alexandrine" last="During">Alexandrine During</name><affiliation><mods:affiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: alexandrine.during@uclouvain.be</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Nutrition Reviews</title><idno type="ISSN">0029-6643</idno><idno type="eISSN">1753-4887</idno><imprint><publisher>Blackwell Publishing Inc</publisher><pubPlace>Malden, USA</pubPlace><date type="published" when="2009-07">2009-07</date><biblScope unit="volume">67</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="363">363</biblScope><biblScope unit="page" to="378">378</biblScope></imprint><idno type="ISSN">0029-6643</idno></series><idno type="istex">A164F73163EDA0A6840767994EE75691F4B14159</idno><idno type="DOI">10.1111/j.1753-4887.2009.00210.x</idno><idno type="ArticleID">NURE210</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0029-6643</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>inflammatory bowel diseases</term><term>intestinal immune response and inflammation</term><term>intracellular signaling pathways</term><term>modulation</term><term>polyphenols</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Inflammatory bowel diseases (IBD) arise from multiple causes, including environmental factors, gut microflora, immunity, and genetic predispositions. In the course of IBD, immune homeostasis and intestinal mucosa barrier integrity are impaired. Among natural preventive treatments that have been identified to date, polyphenols appear as promising candidates. They have been shown to protect against several diseases, including cardiovascular diseases and cancers, and they have anti‐inflammatory properties in non‐intestinal models. This paper will review the literature that has described to date some effects of polyphenols on intestinal inflammation. Studies, conducted using in vivo and in vitro models, provide evidence that pure polyphenolic compounds and natural polyphenolic plant extracts can modulate intestinal inflammation.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Béatrice Romier</name><affiliations><json:string>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</json:string></affiliations></json:item><json:item><name>Yves‐Jacques Schneider</name><affiliations><json:string>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</json:string></affiliations></json:item><json:item><name>Yvan Larondelle</name><affiliations><json:string>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</json:string></affiliations></json:item><json:item><name>Alexandrine During</name><affiliations><json:string>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</json:string><json:string>E-mail: alexandrine.during@uclouvain.be</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>inflammatory bowel diseases</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>intestinal immune response and inflammation</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>intracellular signaling pathways</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>modulation</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>polyphenols</value></json:item></subject><articleId><json:string>NURE210</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>Inflammatory bowel diseases (IBD) arise from multiple causes, including environmental factors, gut microflora, immunity, and genetic predispositions. In the course of IBD, immune homeostasis and intestinal mucosa barrier integrity are impaired. Among natural preventive treatments that have been identified to date, polyphenols appear as promising candidates. They have been shown to protect against several diseases, including cardiovascular diseases and cancers, and they have anti‐inflammatory properties in non‐intestinal models. This paper will review the literature that has described to date some effects of polyphenols on intestinal inflammation. Studies, conducted using in vivo and in vitro models, provide evidence that pure polyphenolic compounds and natural polyphenolic plant extracts can modulate intestinal inflammation.</abstract><qualityIndicators><score>6.32</score><pdfVersion>1.2</pdfVersion><pdfPageSize>594 x 783 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>836</abstractCharCount><pdfWordCount>10546</pdfWordCount><pdfCharCount>76384</pdfCharCount><pdfPageCount>16</pdfPageCount><abstractWordCount>110</abstractWordCount></qualityIndicators><title>Dietary polyphenols can modulate the intestinal inflammatory response</title><refBibs><json:item><author><json:item><name>C Fiocchi</name></json:item></author><host><volume>19</volume><pages><last>326</last><first>325</first></pages><author></author><title>Curr Opin Gastroenterol</title></host><title>More answers and more questions in inflammatory bowel disease</title></json:item><json:item><author><json:item><name>C Pohl</name></json:item><json:item><name>A Hombach</name></json:item><json:item><name>W Kruis</name></json:item></author><host><volume>47</volume><pages><last>70</last><first>57</first></pages><author></author><title>Hepatogastroenterology</title></host><title>Chronic inflammatory bowel disease and cancer</title></json:item><json:item><author><json:item><name>PL Lakatos</name></json:item></author><host><volume>12</volume><pages><last>6108</last><first>6102</first></pages><author></author><title>World J Gastroenterol</title></host><title>Recent trends in the epidemiology of inflammatory bowel diseases: up or down?</title></json:item><json:item><author><json:item><name>C Fiocchi</name></json:item></author><host><volume>115</volume><pages><last>205</last><first>182</first></pages><author></author><title>Gastroenterology</title></host><title>Inflammatory bowel disease: etiology and pathogenesis</title></json:item><json:item><author><json:item><name>CN Bernstein</name></json:item><json:item><name>P Rawsthorne</name></json:item><json:item><name>M Cheang</name></json:item><json:item><name>JF Blanchard</name></json:item></author><host><volume>101</volume><pages><last>1002</last><first>993</first></pages><author></author><title>Am J Gastroenterol</title></host><title>A population‐based case control study of potential risk factors for IBD</title></json:item><json:item><author><json:item><name>N Sakamoto</name></json:item><json:item><name>S Kono</name></json:item><json:item><name>K Wakai</name></json:item></author><host><volume>11</volume><pages><last>163</last><first>154</first></pages><author></author><title>Inflamm Bowel Dis</title></host><title>Dietary risk factors for inflammatory bowel disease: a multicenter case‐control study in Japan</title></json:item><json:item><author><json:item><name>PL Lakatos</name></json:item><json:item><name>S Fischer</name></json:item><json:item><name>L Lakatos</name></json:item><json:item><name>I Gal</name></json:item><json:item><name>J Papp</name></json:item></author><host><volume>12</volume><pages><last>1841</last><first>1829</first></pages><author></author><title>World J Gastroenterol</title></host><title>Current concept on the pathogenesis of inflammatory bowel disease‐crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take “toll”?</title></json:item><json:item><author><json:item><name>SE Girardin</name></json:item><json:item><name>IG Boneca</name></json:item><json:item><name>J Viala</name></json:item></author><host><volume>278</volume><pages><last>8872</last><first>8869</first></pages><author></author><title>J Biol Chem</title></host><title>Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection</title></json:item><json:item><author><json:item><name>VD Peltekova</name></json:item><json:item><name>RF Wintle</name></json:item><json:item><name>LA Rubin</name></json:item></author><host><volume>36</volume><pages><last>475</last><first>471</first></pages><author></author><title>Nat Genet</title></host><title>Functional variants of OCTN cation transporter genes are associated with Crohn disease</title></json:item><json:item><author><json:item><name>M Stoll</name></json:item><json:item><name>B Corneliussen</name></json:item><json:item><name>CM Costello</name></json:item></author><host><volume>36</volume><pages><last>480</last><first>476</first></pages><author></author><title>Nat Genet</title></host><title>Genetic variation in DLG5 is associated with inflammatory bowel disease</title></json:item><json:item><author><json:item><name>RH Duerr</name></json:item><json:item><name>KD Taylor</name></json:item><json:item><name>SR Brant</name></json:item></author><host><volume>314</volume><pages><last>1463</last><first>1461</first></pages><author></author><title>Science</title></host><title>A genome‐wide association study identifies IL23R as an inflammatory bowel disease gene</title></json:item><json:item><author><json:item><name>SJ Brown</name></json:item><json:item><name>L Mayer</name></json:item></author><host><volume>102</volume><pages><last>2069</last><first>2058</first></pages><author></author><title>Am J Gastroenterol</title></host><title>The immune response in inflammatory bowel disease</title></json:item><json:item><author><json:item><name>LR Ferguson</name></json:item><json:item><name>AN Shelling</name></json:item><json:item><name>BL Browning</name></json:item><json:item><name>C Huebner</name></json:item><json:item><name>I Petermann</name></json:item></author><host><volume>622</volume><pages><last>83</last><first>70</first></pages><author></author><title>Mutat Res</title></host><title>Genes, diet and inflammatory bowel disease</title></json:item><json:item><author><json:item><name>JD Taurog</name></json:item><json:item><name>JA Richardson</name></json:item><json:item><name>JT Croft</name></json:item></author><host><volume>180</volume><pages><last>2364</last><first>2359</first></pages><author></author><title>J Exp Med</title></host><title>The germ‐free state prevents development of gut and joint inflammatory disease in HLA‐B27 transgenic rats</title></json:item><json:item><author><json:item><name>O Kanauchi</name></json:item><json:item><name>I Serizawa</name></json:item><json:item><name>Y Araki</name></json:item></author><host><volume>38</volume><pages><last>141</last><first>134</first></pages><author></author><title>J Gastroenterol</title></host><title>Germinated barley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environment</title></json:item><json:item><author><json:item><name>H Takaishi</name></json:item><json:item><name>T Matsuki</name></json:item><json:item><name>A Nakazawa</name></json:item></author><host><volume>298</volume><pages><last>472</last><first>463</first></pages><author></author><title>Int J Med Microbiol</title></host><title>Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease</title></json:item><json:item><author><json:item><name>T Hibi</name></json:item><json:item><name>H Ogata</name></json:item></author><host><volume>41</volume><pages><last>16</last><first>10</first></pages><author></author><title>J Gastroenterol</title></host><title>Novel pathophysiological concepts of inflammatory bowel disease</title></json:item><json:item><author><json:item><name>A Barrie</name></json:item><json:item><name>S Plevy</name></json:item></author><host><volume>35</volume><pages><last>893</last><first>883</first></pages><author></author><title>Gastroenterol Clin North Am</title></host><title>Treatment of immune‐mediated extraintestinal manifestations of inflammatory bowel disease with infliximab</title></json:item><json:item><author><json:item><name>DM Rennick</name></json:item><json:item><name>MM Fort</name></json:item><json:item><name>NJ Davidson</name></json:item></author><host><volume>61</volume><pages><last>396</last><first>389</first></pages><author></author><title>J Leukoc Biol</title></host><title>Studies with IL‐10‐/‐ mice: an overview</title></json:item><json:item><author><json:item><name>R Daig</name></json:item><json:item><name>T Andus</name></json:item><json:item><name>E Aschenbrenner</name></json:item><json:item><name>W Falk</name></json:item><json:item><name>J Scholmerich</name></json:item><json:item><name>V Gross</name></json:item></author><host><volume>38</volume><pages><last>222</last><first>216</first></pages><author></author><title>Gut</title></host><title>Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease</title></json:item><json:item><author><json:item><name>S Fujino</name></json:item><json:item><name>A Andoh</name></json:item><json:item><name>S Bamba</name></json:item></author><host><volume>52</volume><pages><last>70</last><first>65</first></pages><author></author><title>Gut</title></host><title>Increased expression of interleukin 17 in inflammatory bowel disease</title></json:item><json:item><author><json:item><name>A Stallmach</name></json:item><json:item><name>T Giese</name></json:item><json:item><name>C Schmidt</name></json:item><json:item><name>B Ludwig</name></json:item><json:item><name>I Mueller‐Molaian</name></json:item><json:item><name>SC Meuer</name></json:item></author><host><volume>19</volume><pages><last>315</last><first>308</first></pages><author></author><title>Int J Colorectal Dis</title></host><title>Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease</title></json:item><json:item><author><json:item><name>C Fiocchi</name></json:item></author><host><volume>273</volume><pages><last>775</last><first>769</first></pages><author></author><title>Am J Physiol</title></host><title>Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions</title></json:item><json:item><author><json:item><name>TH Yen</name></json:item><json:item><name>NA Wright</name></json:item></author><host><volume>2</volume><pages><last>212</last><first>203</first></pages><author></author><title>Stem Cell Rev</title></host><title>The gastrointestinal tract stem cell niche</title></json:item><json:item><author><json:item><name>P De Santa Barbara</name></json:item><json:item><name>GR Van Den Brink</name></json:item><json:item><name>DJ Roberts</name></json:item></author><host><volume>60</volume><pages><last>1332</last><first>1322</first></pages><author></author><title>Cell Mol Life Sci</title></host><title>Development and differentiation of the intestinal epithelium</title></json:item><json:item><author><json:item><name>RD Newberry</name></json:item><json:item><name>RG Lorenz</name></json:item></author><host><volume>206</volume><pages><last>21</last><first>6</first></pages><author></author><title>Immunol Rev</title></host><title>Organizing a mucosal defense</title></json:item><json:item><author><json:item><name>AJ Ouellette</name></json:item><json:item><name>CL Bevins</name></json:item></author><host><volume>7</volume><pages><last>50</last><first>43</first></pages><author></author><title>Inflamm Bowel Dis</title></host><title>Paneth cell defensins and innate immunity of the small bowel</title></json:item><json:item><author><json:item><name>S Kerneis</name></json:item><json:item><name>A Bogdanova</name></json:item><json:item><name>JP Kraehenbuhl</name></json:item><json:item><name>E Pringault</name></json:item></author><host><volume>277</volume><pages><last>952</last><first>949</first></pages><author></author><title>Science</title></host><title>Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria</title></json:item><json:item><author><json:item><name>T Kucharzik</name></json:item><json:item><name>N Lugering</name></json:item><json:item><name>K Rautenberg</name></json:item></author><host><volume>915</volume><pages><last>183</last><first>171</first></pages><author></author><title>Ann N Y Acad Sci</title></host><title>Role of M cells in intestinal barrier function</title></json:item><json:item><author><json:item><name>JG Magalhaes</name></json:item><json:item><name>I Tattoli</name></json:item><json:item><name>SE Girardin</name></json:item></author><host><volume>19</volume><pages><last>115</last><first>106</first></pages><author></author><title>Semin Immunol</title></host><title>The intestinal epithelial barrier: how to distinguish between the microbial flora and pathogens</title></json:item><json:item><author><json:item><name>K Takeda</name></json:item><json:item><name>S Akira</name></json:item></author><host><volume>5</volume><pages><last>153</last><first>143</first></pages><author></author><title>Cell Microbiol</title></host><title>Toll receptors and pathogen resistance</title></json:item><json:item><author><json:item><name>T Werner</name></json:item><json:item><name>D Haller</name></json:item></author><host><volume>622</volume><pages><last>57</last><first>42</first></pages><author></author><title>Mutat Res</title></host><title>Intestinal epithelial cell signalling and chronic inflammation: from the proteome to specific molecular mechanisms</title></json:item><json:item><author><json:item><name>MR Neutra</name></json:item><json:item><name>NJ Mantis</name></json:item><json:item><name>JP Kraehenbuhl</name></json:item></author><host><volume>2</volume><pages><last>1009</last><first>1004</first></pages><author></author><title>Nat Immunol</title></host><title>Collaboration of epithelial cells with organized mucosal lymphoid tissues</title></json:item><json:item><author><json:item><name>MF Kagnoff</name></json:item><json:item><name>L Eckmann</name></json:item></author><host><volume>100</volume><pages><last>10</last><first>6</first></pages><author></author><title>J Clin Invest</title></host><title>Epithelial cells as sensors for microbial infection</title></json:item><json:item><author><json:item><name>RM Hershberg</name></json:item><json:item><name>LF Mayer</name></json:item></author><host><volume>21</volume><pages><last>128</last><first>123</first></pages><author></author><title>Immunol Today</title></host><title>Antigen processing and presentation by intestinal epithelial cells – polarity and complexity</title></json:item><json:item><author><json:item><name>L Shao</name></json:item><json:item><name>O Kamalu</name></json:item><json:item><name>L Mayer</name></json:item></author><host><volume>206</volume><pages><last>176</last><first>160</first></pages><author></author><title>Immunol Rev</title></host><title>Non‐classical MHC class I molecules on intestinal epithelial cells: mediators of mucosal crosstalk</title></json:item><json:item><author><json:item><name>S Dahan</name></json:item><json:item><name>F Roth‐Walter</name></json:item><json:item><name>P Arnaboldi</name></json:item><json:item><name>S Agarwal</name></json:item><json:item><name>L Mayer</name></json:item></author><host><volume>215</volume><pages><last>253</last><first>243</first></pages><author></author><title>Immunol Rev</title></host><title>Epithelia: lymphocyte interactions in the gut</title></json:item><json:item><author><json:item><name>HC Reinecker</name></json:item><json:item><name>DK Podolsky</name></json:item></author><host><volume>92</volume><pages><last>8357</last><first>8353</first></pages><author></author><title>Proc Natl Acad Sci USA</title></host><title>Human intestinal epithelial cells express functional cytokine receptors sharing the common gamma c chain of the interleukin 2 receptor</title></json:item><json:item><author><json:item><name>MG Neuman</name></json:item></author><host><volume>149</volume><pages><last>186</last><first>173</first></pages><author></author><title>Transl Res</title></host><title>Immune dysfunction in inflammatory bowel disease</title></json:item><json:item><author><json:item><name>A Ravi</name></json:item><json:item><name>P Garg</name></json:item><json:item><name>SV Sitaraman</name></json:item></author><host><volume>13</volume><pages><last>107</last><first>97</first></pages><author></author><title>Inflamm Bowel Dis</title></host><title>Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?</title></json:item><json:item><author><json:item><name>GM Cobrin</name></json:item><json:item><name>MT Abreu</name></json:item></author><host><volume>206</volume><pages><last>295</last><first>277</first></pages><author></author><title>Immunol Rev</title></host><title>Defects in mucosal immunity leading to Crohn's disease</title></json:item><json:item><author><json:item><name>Y Ogura</name></json:item><json:item><name>S Lala</name></json:item><json:item><name>W Xin</name></json:item></author><host><volume>52</volume><pages><last>1597</last><first>1591</first></pages><author></author><title>Gut</title></host><title>Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis</title></json:item><json:item><author><json:item><name>S Keshav</name></json:item></author><host><volume>80</volume><pages><last>508</last><first>500</first></pages><author></author><title>J Leukoc Biol</title></host><title>Paneth cells: leukocyte‐like mediators of innate immunity in the intestine</title></json:item><json:item><author><json:item><name>PJ Barnes</name></json:item></author><host><volume>29</volume><pages><last>870</last><first>867</first></pages><author></author><title>Int J Biochem Cell Biol</title></host><title>Nuclear factor‐kappa B</title></json:item><json:item><author><json:item><name>GH Waetzig</name></json:item><json:item><name>S Schreiber</name></json:item></author><host><volume>18</volume><pages><last>32</last><first>17</first></pages><author></author><title>Aliment Pharmacol Ther</title></host><title>Review article: mitogen‐activated protein kinases in chronic intestinal inflammation – targeting ancient pathways to treat modern diseases</title></json:item><json:item><author><json:item><name>C Jobin</name></json:item><json:item><name>S Haskill</name></json:item><json:item><name>L Mayer</name></json:item><json:item><name>A Panja</name></json:item><json:item><name>RB Sartor</name></json:item></author><host><volume>158</volume><pages><last>234</last><first>226</first></pages><author></author><title>J Immunol</title></host><title>Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells</title></json:item><json:item><author><json:item><name>P Viatour</name></json:item><json:item><name>MP Merville</name></json:item><json:item><name>V Bours</name></json:item><json:item><name>A Chariot</name></json:item></author><host><volume>30</volume><pages><last>52</last><first>43</first></pages><author></author><title>Trends Biochem Sci</title></host><title>Phosphorylation of NF‐kappaB and IkappaB proteins: implications in cancer and inflammation</title></json:item><json:item><author><json:item><name>KJ Campbell</name></json:item><json:item><name>ND Perkins</name></json:item></author><host><volume>73</volume><pages><last>180</last><first>165</first></pages><author></author><title>Biochem Soc Symp</title></host><title>Regulation of NF‐kappaB function</title></json:item><json:item><author><json:item><name>TS Lewis</name></json:item><json:item><name>PS Shapiro</name></json:item><json:item><name>NG Ahn</name></json:item></author><host><volume>74</volume><pages><last>139</last><first>49</first></pages><author></author><title>Adv Cancer Res</title></host><title>Signal transduction through MAP kinase cascades</title></json:item><json:item><author><json:item><name>DW Hommes</name></json:item><json:item><name>MP Peppelenbosch</name></json:item><json:item><name>SJ Van Deventer</name></json:item></author><host><volume>52</volume><pages><last>151</last><first>144</first></pages><author></author><title>Gut</title></host><title>Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti‐inflammatory targets</title></json:item><json:item><author><json:item><name>M Egerton</name></json:item><json:item><name>DR Fitzpatrick</name></json:item><json:item><name>AD Catling</name></json:item><json:item><name>A Kelso</name></json:item></author><host><volume>26</volume><pages><last>2285</last><first>2279</first></pages><author></author><title>Eur J Immunol</title></host><title>Differential activation of T cell cytokine production by the extracellular signal‐regulated kinase (ERK) signaling pathway</title></json:item><json:item><author><json:item><name>YT Ip</name></json:item><json:item><name>RJ Davis</name></json:item></author><host><volume>10</volume><pages><last>219</last><first>205</first></pages><author></author><title>Curr Opin Cell Biol</title></host><title>Signal transduction by the c‐Jun N‐terminal kinase (JNK) – from inflammation to development</title></json:item><json:item><author><json:item><name>GL Johnson</name></json:item><json:item><name>K Nakamura</name></json:item></author><host><volume>1773</volume><pages><last>1348</last><first>1341</first></pages><author></author><title>Biochim Biophys Acta</title></host><title>The c‐jun kinase/stress‐activated pathway: regulation, function and role in human disease</title></json:item><json:item><author><json:item><name>PK Roy</name></json:item><json:item><name>F Rashid</name></json:item><json:item><name>J Bragg</name></json:item><json:item><name>JA Ibdah</name></json:item></author><host><volume>14</volume><pages><last>202</last><first>200</first></pages><author></author><title>World J Gastroenterol</title></host><title>Role of the JNK signal transduction pathway in inflammatory bowel disease</title></json:item><json:item><author><json:item><name>K Ono</name></json:item><json:item><name>J Han</name></json:item></author><host><volume>12</volume><pages><last>13</last><first>1</first></pages><author></author><title>Cell Signal</title></host><title>The p38 signal transduction pathway: activation and function</title></json:item><json:item><author><json:item><name>M Bergmann</name></json:item><json:item><name>L Hart</name></json:item><json:item><name>M Lindsay</name></json:item><json:item><name>PJ Barnes</name></json:item><json:item><name>R Newton</name></json:item></author><host><volume>273</volume><pages><last>6610</last><first>6607</first></pages><author></author><title>J Biol Chem</title></host><title>IkappaBalpha degradation and nuclear factor‐kappaB DNA binding are insufficient for interleukin‐1beta and tumor necrosis factor‐alpha‐induced kappaB‐dependent transcription. Requirement for an additional activation pathway</title></json:item><json:item><author><json:item><name>A Cuenda</name></json:item><json:item><name>S Rousseau</name></json:item></author><host><volume>1773</volume><pages><last>1375</last><first>1358</first></pages><author></author><title>Biochim Biophys Acta</title></host><title>p38 MAP‐kinases pathway regulation, function and role in human diseases</title></json:item><json:item><author><json:item><name>GH Waetzig</name></json:item><json:item><name>D Seegert</name></json:item><json:item><name>P Rosenstiel</name></json:item><json:item><name>S Nikolaus</name></json:item><json:item><name>S Schreiber</name></json:item></author><host><volume>168</volume><pages><last>5351</last><first>5342</first></pages><author></author><title>J Immunol</title></host><title>p38 mitogen‐activated protein kinase is activated and linked to TNF‐alpha signaling in inflammatory bowel disease</title></json:item><json:item><author><json:item><name>C Manach</name></json:item><json:item><name>A Scalbert</name></json:item><json:item><name>C Morand</name></json:item><json:item><name>C Remesy</name></json:item><json:item><name>L Jimenez</name></json:item></author><host><volume>79</volume><pages><last>747</last><first>727</first></pages><author></author><title>Am J Clin Nutr</title></host><title>Polyphenols: food sources and bioavailability</title></json:item><json:item><author><json:item><name>L Bravo</name></json:item></author><host><volume>56</volume><pages><last>333</last><first>317</first></pages><author></author><title>Nutr Rev</title></host><title>Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance</title></json:item><json:item><author><json:item><name>A Scalbert</name></json:item><json:item><name>G Williamson</name></json:item></author><host><volume>130</volume><pages><last>2085</last><first>2073</first></pages><author></author><title>J Nutr</title></host><title>Dietary intake and bioavailability of polyphenols</title></json:item><json:item><author><json:item><name>K Nemeth</name></json:item><json:item><name>GW Plumb</name></json:item><json:item><name>JG Berrin</name></json:item></author><host><volume>42</volume><pages><last>42</last><first>29</first></pages><author></author><title>Eur J Nutr</title></host><title>Deglycosylation by small intestinal epithelial cell beta‐glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans</title></json:item><json:item><author><json:item><name>C Henry‐Vitrac</name></json:item><json:item><name>A Desmouliere</name></json:item><json:item><name>D Girard</name></json:item><json:item><name>JM Merillon</name></json:item><json:item><name>S Krisa</name></json:item></author><host><volume>45</volume><pages><last>382</last><first>376</first></pages><author></author><title>Eur J Nutr</title></host><title>Transport, deglycosylation, and metabolism of trans‐piceid by small intestinal epithelial cells</title></json:item><json:item><author><json:item><name>DE Stevenson</name></json:item><json:item><name>RD Hurst</name></json:item></author><host><volume>64</volume><pages><last>2916</last><first>2900</first></pages><author></author><title>Cell Mol Life Sci</title></host><title>Polyphenolic phytochemicals – just antioxidants or much more?</title></json:item><json:item><author><json:item><name>JB Calixto</name></json:item><json:item><name>MF Otuki</name></json:item><json:item><name>AR Santos</name></json:item></author><host><volume>69</volume><pages><last>983</last><first>973</first></pages><author></author><title>Planta Med</title></host><title>Anti‐inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor kappa B (NF‐kappaB)</title></json:item><json:item><author><json:item><name>JB Calixto</name></json:item><json:item><name>MM Campos</name></json:item><json:item><name>MF Otuki</name></json:item><json:item><name>AR Santos</name></json:item></author><host><volume>70</volume><pages><last>103</last><first>93</first></pages><author></author><title>Planta Med</title></host><title>Anti‐inflammatory compounds of plant origin. Part II. modulation of pro‐inflammatory cytokines, chemokines and adhesion molecules</title></json:item><json:item><author><json:item><name>I Rahman</name></json:item><json:item><name>SK Biswas</name></json:item><json:item><name>PA Kirkham</name></json:item></author><host><volume>72</volume><pages><last>1452</last><first>1439</first></pages><author></author><title>Biochem Pharmacol</title></host><title>Regulation of inflammation and redox signaling by dietary polyphenols</title></json:item><json:item><author><json:item><name>JH Yoon</name></json:item><json:item><name>SJ Baek</name></json:item></author><host><volume>46</volume><pages><last>596</last><first>585</first></pages><author></author><title>Yonsei Med J</title></host><title>Molecular targets of dietary polyphenols with anti‐inflammatory properties</title></json:item><json:item><author><json:item><name>NH Nam</name></json:item></author><host><volume>6</volume><pages><last>951</last><first>945</first></pages><author></author><title>Mini Rev Med Chem</title></host><title>Naturally occurring NF‐kappaB inhibitors</title></json:item><json:item><author><json:item><name>X Han</name></json:item><json:item><name>T Shen</name></json:item><json:item><name>H Lou</name></json:item></author><host><volume>8</volume><pages><last>988</last><first>950</first></pages><author></author><title>Int J Mol Sci</title></host><title>Dietary polyphenols and their biological significance</title></json:item><json:item><author><json:item><name>C Santangelo</name></json:item><json:item><name>R Vari</name></json:item><json:item><name>B Scazzocchio</name></json:item><json:item><name>R Di Benedetto</name></json:item><json:item><name>C Filesi</name></json:item><json:item><name>R Masella</name></json:item></author><host><volume>43</volume><pages><last>405</last><first>394</first></pages><author></author><title>Ann Ist Super Sanita</title></host><title>Polyphenols, intracellular signalling and inflammation</title></json:item><json:item><author><json:item><name>GW Dryden</name></json:item><json:item><name>M Song</name></json:item><json:item><name>C McClain</name></json:item></author><host><volume>22</volume><pages><last>170</last><first>165</first></pages><author></author><title>Curr Opin Gastroenterol</title></host><title>Polyphenols and gastrointestinal diseases</title></json:item><json:item><author><json:item><name>H Shapiro</name></json:item><json:item><name>P Singer</name></json:item><json:item><name>Z Halpern</name></json:item><json:item><name>R Bruck</name></json:item></author><host><volume>56</volume><pages><last>435</last><first>426</first></pages><author></author><title>Gut</title></host><title>Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis</title></json:item><json:item><author><json:item><name>PA Ruiz</name></json:item><json:item><name>A Braune</name></json:item><json:item><name>G Holzlwimmer</name></json:item><json:item><name>L Quintanilla‐Fend</name></json:item><json:item><name>D Haller</name></json:item></author><host><volume>137</volume><pages><last>1215</last><first>1208</first></pages><author></author><title>J Nutr</title></host><title>Quercetin inhibits TNF‐induced NF‐kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells</title></json:item><json:item><author><json:item><name>H Kim</name></json:item><json:item><name>H Kong</name></json:item><json:item><name>B Choi</name></json:item></author><host><volume>22</volume><pages><last>1509</last><first>1499</first></pages><author></author><title>Pharm Res</title></host><title>Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease</title></json:item><json:item><author><json:item><name>PA Ruiz</name></json:item><json:item><name>D Haller</name></json:item></author><host><volume>136</volume><pages><last>671</last><first>664</first></pages><author></author><title>J Nutr</title></host><title>Functional diversity of flavonoids in the inhibition of the proinflammatory NF‐kappaB, IRF, and Akt signaling pathways in murine intestinal epithelial cells</title></json:item><json:item><author><json:item><name>B Romier</name></json:item><json:item><name>J Van De Walle</name></json:item><json:item><name>A During</name></json:item><json:item><name>Y Larondelle</name></json:item><json:item><name>YJ Schneider</name></json:item></author><host><volume>100</volume><pages><last>551</last><first>542</first></pages><author></author><title>Br J Nutr</title></host><title>Modulation of signalling nuclear factor‐kB activation pathway by polyphenols in human intestinal caco‐2 cells</title></json:item><json:item><author><json:item><name>E Navarro‐Peran</name></json:item><json:item><name>J Cabezas‐Herrera</name></json:item><json:item><name>L Sanchez‐Del‐Campo</name></json:item><json:item><name>F Garcia‐Canovas</name></json:item><json:item><name>JN Rodriguez‐Lopez</name></json:item></author><host><volume>57</volume><pages><last>478</last><first>472</first></pages><author></author><title>Inflamm Res</title></host><title>The anti‐inflammatory and anti‐cancer properties of epigallocatechin‐3‐gallate are mediated by folate cycle disruption, adenosine release and NF‐kappaB suppression</title></json:item><json:item><author><json:item><name>KA O'Leary</name></json:item><json:item><name>S De Pascual‐Tereasa</name></json:item><json:item><name>PW Needs</name></json:item><json:item><name>YP Bao</name></json:item><json:item><name>NM O'Brien</name></json:item><json:item><name>G Williamson</name></json:item></author><host><volume>551</volume><pages><last>254</last><first>245</first></pages><author></author><title>Mutat Res</title></host><title>Effect of flavonoids and vitamin E on cyclooxygenase‐2 (COX‐2) transcription</title></json:item><json:item><author><json:item><name>JS Kim</name></json:item><json:item><name>C Jobin</name></json:item></author><host><volume>115</volume><pages><last>387</last><first>375</first></pages><author></author><title>Immunology</title></host><title>The flavonoid luteolin prevents lipopolysaccharide‐induced NF‐kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone‐marrow derived dendritic cells</title></json:item><json:item><author><json:item><name>PN Paradkar</name></json:item><json:item><name>PS Blum</name></json:item><json:item><name>MA Berhow</name></json:item><json:item><name>H Baumann</name></json:item><json:item><name>SM Kuo</name></json:item></author><host><volume>215</volume><pages><last>28</last><first>21</first></pages><author></author><title>Cancer Lett</title></host><title>Dietary isoflavones suppress endotoxin‐induced inflammatory reaction in liver and intestine</title></json:item><json:item><author><json:item><name>K Ishiguro</name></json:item><json:item><name>T Ando</name></json:item><json:item><name>O Maeda</name></json:item></author><host><volume>217</volume><pages><last>42</last><first>35</first></pages><author></author><title>Toxicol Appl Pharmacol</title></host><title>Paeonol attenuates TNBS‐induced colitis by inhibiting NF‐kappaB and STAT1 transactivation</title></json:item><json:item><author><json:item><name>DA Potoka</name></json:item><json:item><name>EP Nadler</name></json:item><json:item><name>X Zhou</name></json:item><json:item><name>XR Zhang</name></json:item><json:item><name>JS Upperman</name></json:item><json:item><name>HR Ford</name></json:item></author><host><volume>14</volume><pages><last>373</last><first>366</first></pages><author></author><title>Shock</title></host><title>Inhibition of NF‐kappaB by IkappaB prevents cytokine‐induced NO production and promotes enterocyte apoptosis in vitro</title></json:item><json:item><author><json:item><name>Y Liu</name></json:item><json:item><name>D Merlin</name></json:item><json:item><name>SL Burst</name></json:item><json:item><name>M Pochet</name></json:item><json:item><name>JL Madara</name></json:item><json:item><name>CA Parkos</name></json:item></author><host><volume>276</volume><pages><last>40166</last><first>40156</first></pages><author></author><title>J Biol Chem</title></host><title>The role of CD47 in neutrophil transmigration. Increased rate of migration correlates with increased cell surface expression of CD47</title></json:item><json:item><author><json:item><name>F Yang</name></json:item><json:item><name>HS Oz</name></json:item><json:item><name>S Barve</name></json:item><json:item><name>WJ De Villiers</name></json:item><json:item><name>CJ McClain</name></json:item><json:item><name>GW Varilek</name></json:item></author><host><volume>60</volume><pages><last>533</last><first>528</first></pages><author></author><title>Mol Pharmacol</title></host><title>The green tea polyphenol (‐)‐epigallocatechin‐3‐gallate blocks nuclear factor‐kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC‐6</title></json:item><json:item><author><json:item><name>SH Lee</name></json:item><json:item><name>DH Sohn</name></json:item><json:item><name>XY Jin</name></json:item><json:item><name>SW Kim</name></json:item><json:item><name>SC Choi</name></json:item><json:item><name>GS Seo</name></json:item></author><host><volume>74</volume><pages><last>880</last><first>870</first></pages><author></author><title>Biochem Pharmacol</title></host><title>2′,4′,6′‐tris(methoxymethoxy) chalcone protects against trinitrobenzene sulfonic acid‐induced colitis and blocks tumor necrosis factor‐alpha‐induced intestinal epithelial inflammation via heme oxygenase 1‐dependent and independent pathways</title></json:item><json:item><author><json:item><name>SH Lee</name></json:item><json:item><name>GS Seo</name></json:item><json:item><name>XY Jin</name></json:item><json:item><name>G Ko</name></json:item><json:item><name>DH Sohn</name></json:item></author><host><volume>81</volume><pages><last>1543</last><first>1535</first></pages><author></author><title>Life Sci</title></host><title>Butein blocks tumor necrosis factor alpha‐induced interleukin 8 and matrix metalloproteinase 7 production by inhibiting p38 kinase and osteopontin mediated signaling events in HT‐29 cells</title></json:item><json:item><author><json:item><name>D Porath</name></json:item><json:item><name>C Riegger</name></json:item><json:item><name>J Drewe</name></json:item><json:item><name>J Schwager</name></json:item></author><host><volume>315</volume><pages><last>1180</last><first>1172</first></pages><author></author><title>J Pharmacol Exp Ther</title></host><title>Epigallocatechin‐3‐gallate impairs chemokine production in human colon epithelial cell lines</title></json:item><json:item><author><json:item><name>T Hong</name></json:item><json:item><name>GB Jin</name></json:item><json:item><name>S Cho</name></json:item><json:item><name>JC Cyong</name></json:item></author><host><volume>68</volume><pages><last>271</last><first>268</first></pages><author></author><title>Planta Med</title></host><title>Evaluation of the anti‐inflammatory effect of baicalein on dextran sulfate sodium‐induced colitis in mice</title></json:item><json:item><author><json:item><name>KH Kwon</name></json:item><json:item><name>A Murakami</name></json:item><json:item><name>T Tanaka</name></json:item><json:item><name>H Ohigashi</name></json:item></author><host><volume>69</volume><pages><last>406</last><first>395</first></pages><author></author><title>Biochem Pharmacol</title></host><title>Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium‐induced experimental colitis in mice: attenuation of pro‐inflammatory gene expression</title></json:item><json:item><author><json:item><name>M Comalada</name></json:item><json:item><name>D Camuesco</name></json:item><json:item><name>S Sierra</name></json:item></author><host><volume>35</volume><pages><last>592</last><first>584</first></pages><author></author><title>Eur J Immunol</title></host><title>In vivo quercitrin anti‐inflammatory effect involves release of quercetin, which inhibits inflammation through down‐regulation of the NF‐kappaB pathway</title></json:item><json:item><author><json:item><name>F Sanchez de Medina</name></json:item><json:item><name>J Galvez</name></json:item><json:item><name>JA Romero</name></json:item><json:item><name>A Zarzuelo</name></json:item></author><host><volume>278</volume><pages><last>779</last><first>771</first></pages><author></author><title>J Pharmacol Exp Ther</title></host><title>Effect of quercitrin on acute and chronic experimental colitis in the rat</title></json:item><json:item><author><json:item><name>F Sanchez de Medina</name></json:item><json:item><name>B Vera</name></json:item><json:item><name>J Galvez</name></json:item><json:item><name>A Zarzuelo</name></json:item></author><host><volume>70</volume><pages><last>3108</last><first>3097</first></pages><author></author><title>Life Sci</title></host><title>Effect of quercitrin on the early stages of hapten induced colonic inflammation in the rat</title></json:item><json:item><author><json:item><name>D Camuesco</name></json:item><json:item><name>M Comalada</name></json:item><json:item><name>ME Rodriguez‐Cabezas</name></json:item></author><host><volume>143</volume><pages><last>918</last><first>908</first></pages><author></author><title>Br J Pharmacol</title></host><title>The intestinal anti‐inflammatory effect of quercitrin is associated with an inhibition in iNOS expression</title></json:item><json:item><author><json:item><name>D Camuesco</name></json:item><json:item><name>M Comalada</name></json:item><json:item><name>A Concha</name></json:item></author><host><volume>25</volume><pages><last>476</last><first>466</first></pages><author></author><title>Clin Nutr</title></host><title>Intestinal anti‐inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n‐3) polyunsaturated fatty acids, in rats with DSS‐induced colitis</title></json:item><json:item><author><json:item><name>J Galvez</name></json:item><json:item><name>T Cruz</name></json:item><json:item><name>E Crespo</name></json:item></author><host><volume>63</volume><pages><last>414</last><first>409</first></pages><author></author><title>Planta Med</title></host><title>Rutoside as mucosal protective in acetic acid‐induced rat colitis</title></json:item><json:item><author><json:item><name>T Cruz</name></json:item><json:item><name>J Galvez</name></json:item><json:item><name>MA Ocete</name></json:item><json:item><name>ME Crespo</name></json:item><json:item><name>LHF Sanchez de Medina</name></json:item><json:item><name>A Zarzuelo</name></json:item></author><host><volume>62</volume><pages><last>695</last><first>687</first></pages><author></author><title>Life Sci</title></host><title>Oral administration of rutoside can ameliorate inflammatory bowel disease in rats</title></json:item><json:item><author><json:item><name>T Cruz</name></json:item><json:item><name>J Galvez</name></json:item><json:item><name>E Crespo</name></json:item><json:item><name>MA Ocete</name></json:item><json:item><name>A Zarzuelo</name></json:item></author><host><volume>67</volume><pages><last>96</last><first>94</first></pages><author></author><title>Planta Med</title></host><title>Effects of silymarin on the acute stage of the trinitrobenzenesulphonic acid model of rat colitis</title></json:item><json:item><author><json:item><name>YS Kim</name></json:item><json:item><name>M Son</name></json:item><json:item><name>JI Ko</name></json:item></author><host><volume>22</volume><pages><last>360</last><first>354</first></pages><author></author><title>Arch Pharm Res</title></host><title>Effect of DA‐6034, a derivative of flavonoid, on experimental animal models of inflammatory bowel disease</title></json:item><json:item><author><json:item><name>ME Crespo</name></json:item><json:item><name>J Galvez</name></json:item><json:item><name>T Cruz</name></json:item><json:item><name>MA Ocete</name></json:item><json:item><name>A Zarzuelo</name></json:item></author><host><volume>65</volume><pages><last>653</last><first>651</first></pages><author></author><title>Planta Med</title></host><title>Anti‐inflammatory activity of diosmin and hesperidin in rat colitis induced by TNBS</title></json:item><json:item><author><json:item><name>I Villegas</name></json:item><json:item><name>C Alarcon de la Lastra</name></json:item><json:item><name>A Orjales</name></json:item><json:item><name>C La Casa</name></json:item></author><host><volume>3</volume><pages><last>1741</last><first>1731</first></pages><author></author><title>Int Immunopharmacol</title></host><title>A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium‐induced colitis in mice</title></json:item><json:item><author><json:item><name>I Villegas</name></json:item><json:item><name>C La Casa</name></json:item><json:item><name>A Orjales</name></json:item><json:item><name>C Alarcon de la Lastra</name></json:item></author><host><volume>460</volume><pages><last>218</last><first>209</first></pages><author></author><title>Eur J Pharmacol</title></host><title>Effects of dosmalfate, a new cytoprotective agent, on acute and chronic trinitrobenzene sulphonic acid‐induced colitis in rats</title></json:item><json:item><author><json:item><name>J Galvez</name></json:item><json:item><name>G Coelho</name></json:item><json:item><name>ME Crespo</name></json:item></author><host><volume>15</volume><pages><last>2039</last><first>2027</first></pages><author></author><title>Aliment Pharmacol Ther</title></host><title>Intestinal anti‐inflammatory activity of morin on chronic experimental colitis in the rat</title></json:item><json:item><author><json:item><name>MA Ocete</name></json:item><json:item><name>J Galvez</name></json:item><json:item><name>ME Crespo</name></json:item></author><host><volume>57</volume><pages><last>270</last><first>261</first></pages><author></author><title>Pharmacology</title></host><title>Effects of morin on an experimental model of acute colitis in rats</title></json:item><json:item><author><json:item><name>H Sadowska‐Krowicka</name></json:item><json:item><name>EE Mannick</name></json:item><json:item><name>PD Oliver</name></json:item></author><host><volume>217</volume><pages><last>357</last><first>351</first></pages><author></author><title>Proc Soc Exp Biol Med</title></host><title>Genistein and gut inflammation: role of nitric oxide</title></json:item><json:item><author><json:item><name>BO Lim</name></json:item></author><host><volume>68</volume><pages><last>2511</last><first>2505</first></pages><author></author><title>Biosci Biotechnol Biochem</title></host><title>Efficacy of wogonin in the production of immunoglobulins and cytokines by mesenteric lymph node lymphocytes in mouse colitis induced with dextran sulfate sodium</title></json:item><json:item><author><json:item><name>K Sato</name></json:item><json:item><name>A Kanazawa</name></json:item><json:item><name>N Ota</name></json:item><json:item><name>T Nakamura</name></json:item><json:item><name>K Fujimoto</name></json:item></author><host><volume>44</volume><pages><last>778</last><first>769</first></pages><author></author><title>J Nutr Sci Vitaminol (Tokyo)</title></host><title>Dietary supplementation of catechins and alpha‐tocopherol accelerates the healing of trinitrobenzene sulfonic acid‐induced ulcerative colitis in rats</title></json:item><json:item><author><json:item><name>M Mochizuki</name></json:item><json:item><name>N Hasegawa</name></json:item></author><host><volume>51</volume><pages><last>364</last><first>362</first></pages><author></author><title>J Health Sci</title></host><title>Protective effect of (‐)‐epigallocatechin gallate on acute experimental colitis</title></json:item><json:item><author><json:item><name>A Ukil</name></json:item><json:item><name>S Maity</name></json:item><json:item><name>PK Das</name></json:item></author><host><volume>149</volume><pages><last>131</last><first>121</first></pages><author></author><title>Br J Pharmacol</title></host><title>Protection from experimental colitis by theaflavin‐3,3′‐digallate correlates with inhibition of IKK and NF‐kappaB activation</title></json:item><json:item><author><json:item><name>S Maity</name></json:item><json:item><name>A Ukil</name></json:item><json:item><name>S Karmakar</name></json:item></author><host><volume>470</volume><pages><last>112</last><first>103</first></pages><author></author><title>Eur J Pharmacol</title></host><title>Thearubigin, the major polyphenol of black tea, ameliorates mucosal injury in trinitrobenzene sulfonic acid‐induced colitis</title></json:item><json:item><author><json:item><name>M Mochizuki</name></json:item><json:item><name>N Hasegawa</name></json:item></author><host><volume>18</volume><pages><last>1028</last><first>1027</first></pages><author></author><title>Phytother Res</title></host><title>Therapeutic efficacy of pycnogenol in experimental inflammatory bowel diseases</title></json:item><json:item><author><json:item><name>K Sugimoto</name></json:item><json:item><name>H Hanai</name></json:item><json:item><name>K Tozawa</name></json:item></author><host><volume>123</volume><pages><last>1922</last><first>1912</first></pages><author></author><title>Gastroenterology</title></host><title>Curcumin prevents and ameliorates trinitrobenzene sulfonic acid‐induced colitis in mice</title></json:item><json:item><author><json:item><name>A Ukil</name></json:item><json:item><name>S Maity</name></json:item><json:item><name>S Karmakar</name></json:item><json:item><name>N Datta</name></json:item><json:item><name>JR Vedasiromoni</name></json:item><json:item><name>PK Das</name></json:item></author><host><volume>139</volume><pages><last>218</last><first>209</first></pages><author></author><title>Br J Pharmacol</title></host><title>Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid‐induced colitis</title></json:item><json:item><author><json:item><name>B Salh</name></json:item><json:item><name>K Assi</name></json:item><json:item><name>V Templeman</name></json:item></author><host><volume>285</volume><pages><last>243</last><first>235</first></pages><author></author><title>Am J Physiol Gastrointest Liver Physiol</title></host><title>Curcumin attenuates DNB‐induced murine colitis</title></json:item><json:item><author><json:item><name>YT Jian</name></json:item><json:item><name>GF Mai</name></json:item><json:item><name>JD Wang</name></json:item><json:item><name>YL Zhang</name></json:item><json:item><name>RC Luo</name></json:item><json:item><name>YX Fang</name></json:item></author><host><volume>11</volume><pages><last>1752</last><first>1747</first></pages><author></author><title>World J Gastroenterol</title></host><title>Preventive and therapeutic effects of NF‐kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid</title></json:item><json:item><author><json:item><name>L Camacho‐Barquero</name></json:item><json:item><name>I Villegas</name></json:item><json:item><name>JM Sanchez‐Calvo</name></json:item></author><host><volume>7</volume><pages><last>342</last><first>333</first></pages><author></author><title>Int Immunopharmacol</title></host><title>Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX‐2 and iNOS expression in chronic experimental colitis</title></json:item><json:item><author><json:item><name>Y Deguchi</name></json:item><json:item><name>A Andoh</name></json:item><json:item><name>O Inatomi</name></json:item></author><host><volume>52</volume><pages><last>2998</last><first>2993</first></pages><author></author><title>Dig Dis Sci</title></host><title>Curcumin prevents the development of dextran sulfate sodium (DSS)‐induced experimental colitis</title></json:item><json:item><author><json:item><name>C Luceri</name></json:item><json:item><name>F Guglielmi</name></json:item><json:item><name>M Lodovici</name></json:item><json:item><name>L Giannini</name></json:item><json:item><name>L Messerini</name></json:item><json:item><name>P Dolara</name></json:item></author><host><volume>39</volume><pages><last>1133</last><first>1128</first></pages><author></author><title>Scand J Gastroenterol</title></host><title>Plant phenolic 4‐coumaric acid protects against intestinal inflammation in rats</title></json:item><json:item><author><json:item><name>LC Di Stasi</name></json:item><json:item><name>D Camuesco</name></json:item><json:item><name>A Nieto</name></json:item><json:item><name>W Vilegas</name></json:item><json:item><name>A Zarzuelo</name></json:item><json:item><name>J Galvez</name></json:item></author><host><volume>70</volume><pages><last>320</last><first>315</first></pages><author></author><title>Planta Med</title></host><title>Intestinal anti‐inflammatory activity of paepalantine, an isocoumarin isolated from the capitula of Paepalanthus bromelioides, in the trinitrobenzenesulphonic acid model of rat colitis</title></json:item><json:item><author><json:item><name>AR Martin</name></json:item><json:item><name>I Villegas</name></json:item><json:item><name>C La Casa</name></json:item><json:item><name>CA De La Lastra</name></json:item></author><host><volume>67</volume><pages><last>1410</last><first>1399</first></pages><author></author><title>Biochem Pharmacol</title></host><title>Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats</title></json:item><json:item><author><json:item><name>AR Martin</name></json:item><json:item><name>I Villegas</name></json:item><json:item><name>M Sanchez‐Hidalgo</name></json:item><json:item><name>CA De La Lastra</name></json:item></author><host><volume>147</volume><pages><last>885</last><first>873</first></pages><author></author><title>Br J Pharmacol</title></host><title>The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model</title></json:item><json:item><author><json:item><name>YH Kim</name></json:item><json:item><name>HS Kwon</name></json:item><json:item><name>DH Kim</name></json:item></author><host><volume>8</volume><pages><last>1702</last><first>1695</first></pages><author></author><title>Int Immunopharmacol</title></host><title>Piceatannol, a stilbene present in grapes, attenuates dextran sulfate sodium‐induced colitis</title></json:item><json:item><author><json:item><name>HS Kwon</name></json:item><json:item><name>SM Oh</name></json:item><json:item><name>JK Kim</name></json:item></author><host><volume>151</volume><pages><last>173</last><first>165</first></pages><author></author><title>Clin Exp Immunol</title></host><title>Glabridin, a functional compound of liquorice, attenuates colonic inflammation in mice with dextran sulphate sodium‐induced colitis</title></json:item><json:item><author><json:item><name>H Hanai</name></json:item><json:item><name>T Iida</name></json:item><json:item><name>K Takeuchi</name></json:item></author><host><volume>4</volume><pages><last>1506</last><first>1502</first></pages><author></author><title>Clin Gastroenterol Hepatol</title></host><title>Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double‐blind, placebo‐controlled trial</title></json:item><json:item><author><json:item><name>AC Luchini</name></json:item><json:item><name>P Rodrigues‐Orsi</name></json:item><json:item><name>SH Cestari</name></json:item></author><host><volume>31</volume><pages><last>1350</last><first>1343</first></pages><author></author><title>Biol Pharm Bull</title></host><title>Intestinal anti‐inflammatory activity of coumarin and 4‐hydroxycoumarin in the trinitrobenzenesulphonic acid model of rat colitis</title></json:item><json:item><author><json:item><name>E Tedeschi</name></json:item><json:item><name>M Menegazzi</name></json:item><json:item><name>Y Yao</name></json:item><json:item><name>H Suzuki</name></json:item><json:item><name>U Forstermann</name></json:item><json:item><name>H Kleinert</name></json:item></author><host><volume>65</volume><pages><last>120</last><first>111</first></pages><author></author><title>Mol Pharmacol</title></host><title>Green tea inhibits human inducible nitric‐oxide synthase expression by down‐regulating signal transducer and activator of transcription‐1alpha activation</title></json:item><json:item><author><json:item><name>MI Netsch</name></json:item><json:item><name>H Gutmann</name></json:item><json:item><name>C Aydogan</name></json:item><json:item><name>J Drewe</name></json:item></author><host><volume>72</volume><pages><last>702</last><first>697</first></pages><author></author><title>Planta Med</title></host><title>Green tea extract induces interleukin‐8 (IL‐8) mRNA and protein expression but specifically inhibits IL‐8 secretion in caco‐2 cells</title></json:item><json:item><author><json:item><name>GW Varilek</name></json:item><json:item><name>F Yang</name></json:item><json:item><name>EY Lee</name></json:item></author><host><volume>131</volume><pages><last>2039</last><first>2034</first></pages><author></author><title>J Nutr</title></host><title>Green tea polyphenol extract attenuates inflammation in interleukin‐2‐deficient mice, a model of autoimmunity</title></json:item><json:item><author><json:item><name>E Mazzon</name></json:item><json:item><name>C Muia</name></json:item><json:item><name>RD Paola</name></json:item></author><host><volume>39</volume><pages><last>1025</last><first>1017</first></pages><author></author><title>Free Radic Res</title></host><title>Green tea polyphenol extract attenuates colon injury induced by experimental colitis</title></json:item><json:item><author><json:item><name>HS Oz</name></json:item><json:item><name>TS Chen</name></json:item><json:item><name>CJ McClain</name></json:item><json:item><name>WJ De Villiers</name></json:item></author><host><volume>16</volume><pages><last>304</last><first>297</first></pages><author></author><title>J Nutr Biochem</title></host><title>Antioxidants as novel therapy in a murine model of colitis</title></json:item><json:item><author><json:item><name>B Wessner</name></json:item><json:item><name>EM Strasser</name></json:item><json:item><name>N Koitz</name></json:item><json:item><name>C Schmuckenschlager</name></json:item><json:item><name>N Unger‐Manhart</name></json:item><json:item><name>E Roth</name></json:item></author><host><volume>137</volume><pages><last>640</last><first>634</first></pages><author></author><title>J Nutr</title></host><title>Green tea polyphenol administration partly ameliorates chemotherapy‐induced side effects in the small intestine of mice</title></json:item><json:item><author><json:item><name>JS Kim</name></json:item><json:item><name>AS Narula</name></json:item><json:item><name>C Jobin</name></json:item></author><host><volume>141</volume><pages><last>297</last><first>288</first></pages><author></author><title>Clin Exp Immunol</title></host><title>Salvia miltiorrhiza water‐soluble extract, but not its constituent salvianolic acid B, abrogates LPS‐induced NF‐kappaB signalling in intestinal epithelial cells</title></json:item><json:item><author><json:item><name>B Romier‐Crouzet</name></json:item><json:item><name>J Van de Walle</name></json:item><json:item><name>A During</name></json:item></author><host><volume>47</volume><pages><last>1230</last><first>1221</first></pages><author></author><title>Food Chem Toxicol</title></host><title>Inhibition of inflammatory mediators by polyphenolic plant extracts in human intestinal Caco‐2 cells</title></json:item><json:item><author><json:item><name>BP Burnett</name></json:item><json:item><name>Q Jia</name></json:item><json:item><name>Y Zhao</name></json:item><json:item><name>RM Levy</name></json:item></author><host><volume>10</volume><pages><last>451</last><first>442</first></pages><author></author><title>J Med Food</title></host><title>A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5‐lipoxygenase to reduce inflammation</title></json:item><json:item><author><json:item><name>J Galvez</name></json:item><json:item><name>J De Souza Gracioso</name></json:item><json:item><name>D Camuesco</name></json:item><json:item><name>W Vilegas</name></json:item><json:item><name>AR Monteiro Souza Brito</name></json:item><json:item><name>A Zarzuelo</name></json:item></author><host><volume>77</volume><pages><last>520</last><first>515</first></pages><author></author><title>Fitoterapia</title></host><title>Intestinal antiinflammatory activity of a lyophilized infusion of Turnera ulmifolia in TNBS rat colitis</title></json:item><json:item><author><json:item><name>R Di Paola</name></json:item><json:item><name>E Mazzon</name></json:item><json:item><name>C Muia</name></json:item></author><host><volume>16</volume><pages><last>130</last><first>118</first></pages><author></author><title>Nitric Oxide</title></host><title>Protective effect of Hypericum perforatum in zymosan‐induced multiple organ dysfunction syndrome: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity</title></json:item><json:item><author><json:item><name>R Canali</name></json:item><json:item><name>F Vignolini</name></json:item><json:item><name>F Nobili</name></json:item><json:item><name>E Mengheri</name></json:item></author><host><volume>28</volume><pages><last>1670</last><first>1661</first></pages><author></author><title>Free Radic Biol Med</title></host><title>Reduction of oxidative stress and cytokine‐induced neutrophil chemoattractant (CINC) expression by red wine polyphenols in zinc deficiency induced intestinal damage of rat</title></json:item><json:item><author><json:item><name>Y Ogawa</name></json:item><json:item><name>K Kanatsu</name></json:item><json:item><name>T Iino</name></json:item></author><host><volume>71</volume><pages><last>839</last><first>827</first></pages><author></author><title>Life Sci</title></host><title>Protection against dextran sulfate sodium‐induced colitis by microspheres of ellagic acid in rats</title></json:item></refBibs><genre><json:string>article</json:string></genre><host><volume>67</volume><publisherId><json:string>NURE</json:string></publisherId><pages><total>16</total><last>378</last><first>363</first></pages><issn><json:string>0029-6643</json:string></issn><issue>7</issue><genre><json:string>journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1753-4887</json:string></eissn><title>Nutrition Reviews</title><doi><json:string>10.1111/(ISSN)1753-4887</json:string></doi></host><categories><wos><json:string>science</json:string><json:string>nutrition & dietetics</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>biomedical research</json:string><json:string>nutrition & dietetics</json:string></scienceMetrix></categories><publicationDate>2009</publicationDate><copyrightDate>2009</copyrightDate><doi><json:string>10.1111/j.1753-4887.2009.00210.x</json:string></doi><id>A164F73163EDA0A6840767994EE75691F4B14159</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/A164F73163EDA0A6840767994EE75691F4B14159/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/A164F73163EDA0A6840767994EE75691F4B14159/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/A164F73163EDA0A6840767994EE75691F4B14159/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Dietary polyphenols can modulate the intestinal inflammatory response</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Inc</publisher><pubPlace>Malden, USA</pubPlace><availability><p>© 2009 International Life Sciences Institute</p></availability><date>2009</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Dietary polyphenols can modulate the intestinal inflammatory response</title><author xml:id="author-1"><persName><forename type="first">Béatrice</forename><surname>Romier</surname></persName><affiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</affiliation></author><author xml:id="author-2"><persName><forename type="first">Yves‐Jacques</forename><surname>Schneider</surname></persName><affiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</affiliation></author><author xml:id="author-3"><persName><forename type="first">Yvan</forename><surname>Larondelle</surname></persName><affiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</affiliation></author><author xml:id="author-4"><persName><forename type="first">Alexandrine</forename><surname>During</surname></persName><email>alexandrine.during@uclouvain.be</email><affiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</affiliation></author></analytic><monogr><title level="j">Nutrition Reviews</title><idno type="pISSN">0029-6643</idno><idno type="eISSN">1753-4887</idno><idno type="DOI">10.1111/(ISSN)1753-4887</idno><imprint><publisher>Blackwell Publishing Inc</publisher><pubPlace>Malden, USA</pubPlace><date type="published" when="2009-07"></date><biblScope unit="volume">67</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="363">363</biblScope><biblScope unit="page" to="378">378</biblScope></imprint></monogr><idno type="istex">A164F73163EDA0A6840767994EE75691F4B14159</idno><idno type="DOI">10.1111/j.1753-4887.2009.00210.x</idno><idno type="ArticleID">NURE210</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2009</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Inflammatory bowel diseases (IBD) arise from multiple causes, including environmental factors, gut microflora, immunity, and genetic predispositions. In the course of IBD, immune homeostasis and intestinal mucosa barrier integrity are impaired. Among natural preventive treatments that have been identified to date, polyphenols appear as promising candidates. They have been shown to protect against several diseases, including cardiovascular diseases and cancers, and they have anti‐inflammatory properties in non‐intestinal models. This paper will review the literature that has described to date some effects of polyphenols on intestinal inflammation. Studies, conducted using in vivo and in vitro models, provide evidence that pure polyphenolic compounds and natural polyphenolic plant extracts can modulate intestinal inflammation.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>keywords</head><item><term>inflammatory bowel diseases</term></item><item><term>intestinal immune response and inflammation</term></item><item><term>intracellular signaling pathways</term></item><item><term>modulation</term></item><item><term>polyphenols</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2009-07">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/A164F73163EDA0A6840767994EE75691F4B14159/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Inc</publisherName><publisherLoc>Malden, USA</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1753-4887</doi><issn type="print">0029-6643</issn><issn type="electronic">1753-4887</issn><idGroup><id type="product" value="NURE"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="NUTRITION REVIEWS">Nutrition Reviews</title></titleGroup></publicationMeta><publicationMeta level="part" position="07007"><doi origin="wiley">10.1111/nure.2009.67.issue-7</doi><numberingGroup><numbering type="journalVolume" number="67">67</numbering><numbering type="journalIssue" number="7">7</numbering></numberingGroup><coverDate startDate="2009-07">July 2009</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="1" status="forIssue"><doi origin="wiley">10.1111/j.1753-4887.2009.00210.x</doi><idGroup><id type="unit" value="NURE210"></id></idGroup><countGroup><count type="pageTotal" number="16"></count></countGroup><titleGroup><title type="tocHeading1">Lead Article</title></titleGroup><copyright>© 2009 International Life Sciences Institute</copyright><eventGroup><event type="firstOnline" date="2009-06-26"></event><event type="publishedOnlineFinalForm" date="2009-06-26"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.15 mode:FullText source:FullText result:FullText" date="2010-08-12"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-03"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-03"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="363">363</numbering><numbering type="pageLast" number="378">378</numbering></numberingGroup><correspondenceTo><i>A During</i>, Laboratoire de Biochimie Cellulaire, Croix du Sud, 5, Université catholique de Louvain, B 1348 Louvain‐la‐Neuve, Belgium. E‐mail: <email>alexandrine.during@uclouvain.be</email>, Phone: +32(0)‐10‐47‐30‐39, Fax: +32(0)‐10‐47‐48‐95.</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:NURE.NURE210.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="5"></count><count type="formulaTotal" number="0"></count><count type="referenceTotal" number="138"></count><count type="wordTotal" number="12489"></count><count type="linksPubMed" number="0"></count><count type="linksCrossRef" number="0"></count></countGroup><titleGroup><title type="main">Dietary polyphenols can modulate the intestinal inflammatory response</title><title type="shortAuthors">Nutrition Reviews<sup>©</sup>, Vol. 67, No. 7</title><title type="short">Nutrition Reviews<sup>©</sup>, Vol. 67, No. 7</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1"><personName><givenNames>Béatrice</givenNames><familyName>Romier</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a1"><personName><givenNames>Yves‐Jacques</givenNames><familyName>Schneider</familyName></personName></creator><creator creatorRole="author" xml:id="cr3" affiliationRef="#a1"><personName><givenNames>Yvan</givenNames><familyName>Larondelle</familyName></personName></creator><creator creatorRole="author" xml:id="cr4" affiliationRef="#a1" corresponding="yes"><personName><givenNames>Alexandrine</givenNames><familyName>During</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="a1" countryCode="BE"><unparsedAffiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en"><keyword xml:id="k1">inflammatory bowel diseases</keyword><keyword xml:id="k2">intestinal immune response and inflammation</keyword><keyword xml:id="k3">intracellular signaling pathways</keyword><keyword xml:id="k4">modulation</keyword><keyword xml:id="k5">polyphenols</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><p>Inflammatory bowel diseases (IBD) arise from multiple causes, including environmental factors, gut microflora, immunity, and genetic predispositions. In the course of IBD, immune homeostasis and intestinal mucosa barrier integrity are impaired. Among natural preventive treatments that have been identified to date, polyphenols appear as promising candidates. They have been shown to protect against several diseases, including cardiovascular diseases and cancers, and they have anti‐inflammatory properties in non‐intestinal models. This paper will review the literature that has described to date some effects of polyphenols on intestinal inflammation. Studies, conducted using in vivo and in vitro models, provide evidence that pure polyphenolic compounds and natural polyphenolic plant extracts can modulate intestinal inflammation.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Dietary polyphenols can modulate the intestinal inflammatory response</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Nutrition Reviews©, Vol. 67, No. 7</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Dietary polyphenols can modulate the intestinal inflammatory response</title></titleInfo><name type="personal"><namePart type="given">Béatrice</namePart><namePart type="family">Romier</namePart><affiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Yves‐Jacques</namePart><namePart type="family">Schneider</namePart><affiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Yvan</namePart><namePart type="family">Larondelle</namePart><affiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Alexandrine</namePart><namePart type="family">During</namePart><affiliation>Biochimie cellulaire, nutritionnelle & toxicologique, Institut des Sciences de la Vie & UCL, Académie universitaire Louvain, Louvain‐la‐Neuve, Belgium</affiliation><affiliation>E-mail: alexandrine.during@uclouvain.be</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Blackwell Publishing Inc</publisher><place><placeTerm type="text">Malden, USA</placeTerm></place><dateIssued encoding="w3cdtf">2009-07</dateIssued><copyrightDate encoding="w3cdtf">2009</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="tables">5</extent><extent unit="references">138</extent><extent unit="words">12489</extent></physicalDescription><abstract lang="en">Inflammatory bowel diseases (IBD) arise from multiple causes, including environmental factors, gut microflora, immunity, and genetic predispositions. In the course of IBD, immune homeostasis and intestinal mucosa barrier integrity are impaired. Among natural preventive treatments that have been identified to date, polyphenols appear as promising candidates. They have been shown to protect against several diseases, including cardiovascular diseases and cancers, and they have anti‐inflammatory properties in non‐intestinal models. This paper will review the literature that has described to date some effects of polyphenols on intestinal inflammation. Studies, conducted using in vivo and in vitro models, provide evidence that pure polyphenolic compounds and natural polyphenolic plant extracts can modulate intestinal inflammation.</abstract><subject lang="en"><genre>keywords</genre><topic>inflammatory bowel diseases</topic><topic>intestinal immune response and inflammation</topic><topic>intracellular signaling pathways</topic><topic>modulation</topic><topic>polyphenols</topic></subject><relatedItem type="host"><titleInfo><title>Nutrition Reviews</title></titleInfo><genre type="journal">journal</genre><identifier type="ISSN">0029-6643</identifier><identifier type="eISSN">1753-4887</identifier><identifier type="DOI">10.1111/(ISSN)1753-4887</identifier><identifier type="PublisherID">NURE</identifier><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>67</number></detail><detail type="issue"><caption>no.</caption><number>7</number></detail><extent unit="pages"><start>363</start><end>378</end><total>16</total></extent></part></relatedItem><identifier type="istex">A164F73163EDA0A6840767994EE75691F4B14159</identifier><identifier type="DOI">10.1111/j.1753-4887.2009.00210.x</identifier><identifier type="ArticleID">NURE210</identifier><accessCondition type="use and reproduction" contentType="copyright">© 2009 International Life Sciences Institute</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Publishing Inc</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Bois/explor/CheneBelgiqueV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001535 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001535 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Bois
|area= CheneBelgiqueV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:A164F73163EDA0A6840767994EE75691F4B14159
|texte= Dietary polyphenols can modulate the intestinal inflammatory response
}}
| This area was generated with Dilib version V0.6.27. |  |